SANOFI Stock View

Sanofi India Ltd

SANOFI Stock View

(NSE)

Trade

₹ 8,218.75

192.55 | 2.40

Market Cap ₹( Cr.)
189,282.90

Proj. P/E (x)
31.26

Proj. P/BV (x)
12.01

Proj. ROE (%)
48.25

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
27,372.75

Last Updated On.
26-Nov-2023

 

Copy Link

Sanofi India Limited is a healthcare company. The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. It has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. It sells its products through independent distributors primarily in India. It also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data